Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 7.9B | 9.2B | 8.4B | 9.4B |
Cost of revenue | 3.3B | 4.0B | 3.6B | 4.3B |
Gross profit | 4.6B | 5.2B | 4.7B | 5.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.5B | 2.1B | 1.9B | 2.1B |
Operating income | 746.4M | 1.1B | 843.8M | 977.4M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 347.6M | 311.1M | 317.9M | 308.1M |
Other income expense | — | — | — | — |
Pretax income | 621.8M | 773.1M | 697.8M | 2.2B |
Tax provision | 162.6M | 186.1M | 178.0M | 430.6M |
Net income | 459.2M | 587.0M | 519.8M | 1.7B |
Basic EPS | — | 4.6 | 4.0 | 13.5 |
Diluted EPS | — | 4.6 | 4.0 | 13.5 |
Basic average shares | — | 128.4M | 128.7M | 128.6M |
Diluted average shares | — | 128.4M | 128.7M | 128.6M |
EBITDA | 2.0B | 2.1B | 1.9B | 2.0B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |